Skip to main content
. 2015 Sep 14;112(39):12145–12150. doi: 10.1073/pnas.1516428112

Fig. S2.

Fig. S2.

Defective proliferation of BCRneg B cells. (A) B cells from B1-8f/+, CreED-30, bcl-2tg mice were purified and treated with 4-OH-tamoxifen for 7 d before CFSE labeling and stimulation with the indicated mitogen for 3 d. Data are representative of three biological replicates. (B) Ex vivo isolated B cells from B1-8f/JHT, CD21-Cre, bcl-2tg mice were labeled with CFSE and cultured in medium or with CpG for 3 d. ToPro3−, CD19+ cells are shown. Data are representative of two biological replicates.